Clinical Trial Update: Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Zafirlukast for marker-relapsed ovarian cancer has completed, with results posted. The study was sponsored by Beth Israel Deac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Zafirlukast (zafirlukast)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-12-11